Vildagliptin-Metformin
In StockVildagliptin–Metformin is a prescription medicine used to help manage type 2 diabetes mellitus. It combines a dipeptidyl peptidase-4 (DPP-4) inhibitor with a biguanide to support blood glucose control. Vildagliptin helps enhance incretin hormone activity, while metformin helps reduce glucose production in the liver and improve insulin sensitivity. Use only as directed on the product label or by a healthcare professional.
What is Vildagliptin–Metformin?
Vildagliptin–Metformin is a prescription medication used to help control blood sugar levels in adults with Type 2 diabetes. It combines two medicines that work through different mechanisms to improve how the body regulates glucose.
This combination contains:
Vildagliptin
Metformin
Doctors may prescribe this medicine when lifestyle measures and single-drug therapy do not provide adequate blood glucose control.
Common Uses
Healthcare providers may use Vildagliptin–Metformin to:
Improve blood sugar control in adults with Type 2 diabetes
Support glucose management alongside diet and physical activity
Reduce the risk of complications associated with poorly controlled diabetes
Available Formulations and Strengths
This medicine is typically available as oral tablets containing fixed-dose combinations of Vildagliptin and Metformin.
Strengths may vary by manufacturer and region. The prescribing healthcare professional determines the most suitable formulation and dosing plan.
What is the Recommended Dosage of Vildagliptin–Metformin?
The appropriate dosage varies depending on the patient’s medical condition and treatment response. A licensed healthcare provider determines the correct dose.
Factors influencing dosage
Doctors may consider:
Current blood glucose levels
Severity of Type 2 diabetes
Kidney and liver function
Patient age
Other diabetes medications being used
Dosage Form
Vildagliptin–Metformin is supplied as oral tablets that are usually taken with meals.
Important dosing guidance
Tablets are generally taken once or twice daily with food, as directed by a healthcare provider.
Dose adjustments may occur gradually to achieve stable blood sugar control.
Treatment decisions should follow guidance from a licensed endocrinologist or primary care physician.
Patients should not adjust the dose or discontinue treatment without medical advice.
How Vildagliptin–Metformin Works
The two medicines in this combination help regulate blood sugar through complementary actions.
Vildagliptin
Vildagliptin blocks the enzyme dipeptidyl peptidase-4 (DPP-4). This action increases incretin hormones that help regulate blood glucose after meals. It promotes insulin release when blood sugar levels rise and reduces glucose production.
Metformin
Metformin decreases glucose production in the liver and improves the body’s response to insulin.
Together, these effects may help:
Lower blood glucose levels
Improve insulin efficiency
Support long-term diabetes management
The medication helps manage Type 2 diabetes, but it does not cure the condition.
Is a Prescription Required to Buy Vildagliptin–Metformin Online?
Yes. Vildagliptin–Metformin is a prescription-only medication.
Patients must obtain a prescription from a licensed healthcare professional, such as a:
Endocrinology specialist
Primary care physician managing diabetes treatment
Safe purchasing practices
Patients should:
Buy medicines only from licensed pharmacies
Avoid websites selling prescription drugs without medical verification
Be cautious of counterfeit or unregulated medications
Appropriate medical supervision is necessary when managing diabetes medications.
Side Effects of Vildagliptin–Metformin
Like many medications used for diabetes, this combination may cause side effects. Most are mild but some require medical attention.
Common Side Effects
Patients may experience:
Nausea
Diarrhea
Stomach discomfort
Headache
Dizziness
Mild upper respiratory symptoms
These effects are often temporary and may improve as the body adjusts to treatment.
Serious Side Effects
Rare but serious side effects may include:
Severe abdominal pain related to Pancreatitis
Symptoms of Lactic acidosis, a rare but serious condition associated with metformin
Allergic reactions such as swelling, rash, or breathing difficulty
Signs of liver problems such as yellowing of skin or eyes
Immediate medical attention should be sought if serious symptoms occur.
Drug Interactions
Vildagliptin–Metformin may interact with other medicines that affect blood sugar levels or metabolism.
Major interaction categories
Other diabetes medications
Insulin
Sulfonylureas
Medications affecting liver enzymes
Certain blood pressure or heart medications
Over-the-counter medicines and supplements
Patients should inform their healthcare provider about:
OTC medications
Herbal supplements
Vitamins
Nutritional or weight-loss products
Providing a complete medication list helps reduce the risk of interactions.
Safety & Important Considerations
Several health factors should be considered before starting this medication.
Kidney Function
Because Metformin is cleared through the kidneys, patients with kidney impairment may require dose adjustments or alternative therapy.
Liver Conditions
Patients with liver disease may require monitoring because the medication is metabolized partly in the liver.
Heart and Metabolic Conditions
Patients with serious illness, dehydration, or infection should consult a healthcare provider regarding treatment safety.
Pregnancy and Breastfeeding
Patients who are pregnant, planning pregnancy, or breastfeeding should discuss diabetes management options with their healthcare provider.
Monitoring Requirements
Healthcare providers may monitor:
Blood glucose levels
Kidney function
Liver function
Symptoms related to pancreatic health
Regular follow-up appointments help ensure safe and effective treatment.
Who This Medication Is For
Vildagliptin–Metformin is typically prescribed for adults with Type 2 diabetes who require improved blood sugar control.
It may be recommended when:
Diet and exercise alone are insufficient
Single-drug therapy does not provide adequate glucose control
Combination therapy is considered appropriate
Treatment decisions are based on individual metabolic health and clinical evaluation.
Who Should Not Take Vildagliptin–Metformin
Certain individuals should avoid this medication unless directed by a healthcare professional.
Contraindications
Patients should generally not take this medication if they:
Have severe kidney disease
Have metabolic acidosis
Have Type 1 diabetes
Have a known allergy to Vildagliptin or Metformin
Precautions
Patients with the following conditions should discuss risks with their healthcare provider:
Liver disease
History of pancreatitis
Severe infections or dehydration
Heart failure or metabolic disorders
A medical evaluation is necessary before starting treatment.
What to Do If You Miss a Dose
If a dose is missed:
Take the missed dose as soon as you remember.
If the next scheduled dose is near, skip the missed dose.
Continue the regular dosing schedule.
Do not take two doses at the same time.
If multiple doses are missed or blood sugar levels change significantly, consult a healthcare professional.
Alternatives to Vildagliptin–Metformin
Several other medications may be used to manage Type 2 diabetes, including:
Sitagliptin
Empagliflozin
Semaglutide
Glimepiride
Each medication works differently to help regulate blood sugar levels. Treatment changes should only occur under supervision of a licensed healthcare professional.
Storage Instructions
To maintain medication safety:
Store tablets at room temperature.
Keep away from moisture, heat, and direct sunlight.
Store medication in the original packaging when possible.
Keep out of reach of children and pets.
Unused or expired medication should be disposed of according to pharmacy guidance.
Disclaimer
Educational Notice
This page is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Patients should consult a licensed endocrinologist or qualified healthcare professional before starting, changing, or stopping Vildagliptin–Metformin therapy.
All treatment decisions must be based on a complete clinical evaluation and individualized medical assessment performed by a qualified specialist.